Navigation Links
Soligenix Receives $574,000 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program
Date:1/26/2012

ance, prospects and opportunities. Statements that are not historical facts, such as "anticipate," "expect," "believe," "intend," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, SGX202, SGX203, SGX204, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the Data Safety Monitoring Board's recent determination disclosed in our Form 8-K dated September 15, 2011 recommending that Soligenix stop its confirmatory Phase 3 clinical trial of orB
'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Initiates Next Generation Anthrax Vaccine Development Program Under Agreement With Harvard University
2. Soligenix Reports Third Quarter 2011 Financial Results
3. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
4. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
5. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
6. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
7. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
8. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
9. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
10. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
11. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014   Vestagen Technical ... the patient experience at hospitals. The myComfort™ line of ... active barrier fabric that is fluid repellant, breathable and ... inhibit the growth of bacteria on the fabric i ... clothing plays in the chain of transmission. We want ...
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... 2014 CorMedix Inc. ("CorMedix") (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... amendment and restatement of its outstanding Series C-2, ... warrants, as well as the warrants issued in ... to remove anti-dilution, price reset and certain change ...
Breaking Medicine Technology:New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... 2011 Cellular Dynamics International (CDI) today announced the ... Blood demonstrating for the first time a methodology ... of banked blood samples through the creation of induced ... "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent ...
... Advanced Sterilization Products (ASP) announced today the ... GLOSAIR™ Healthcare Environmental Decontamination – that provides effective, ... operating suites to reduce the risk of patient ... scientific consensus that the patient environment is a ...
Cached Medicine Technology:Cellular Dynamics International Unlocks the Potential of Banked Blood Samples 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 3ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 4ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 5
(Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Top10BestSEOHosting.com ... announced the most recommended companies for the webmasters ... at affordable rates. , The senior spokesman ... http://www.arvixe.com/6883.html ), Bluehost and HostMonster are the excellent ... managed to provide a wide range of advanced ...
(Date:9/16/2014)... report a poorer experience of care during pregnancy and ... care, suggests a new study published today (17 September) ... Gynaecology ( BJOG ). , Differences in health ... many areas and have provided the focus for national ... , The Oxford University study, funded by the National ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2
... the most common form of brain cancer might fare better ... alone . ,Based on findings of the study it ... known as glioblastoma receive surgery to remove as much of ... The current study compared 573 patients with glioblastomas who were ...
... to a study in Journal of Dental Research, caries in ... ,A primary tooth can have caries for a wide ... socio-economic status, years of exposure to water fluoridation, disturbance to ... all these differences, can caries in primary teeth have long-term ...
... variant that may increase the risk of late-onset Alzheimer’s ... understanding of the disease and new prevention and treatment ... specific changes in the gene in a protein called ... ,In previous studies, researchers studied Alzheimer’s patients and ...
... recent issue of Journal of American Medical Association, researchers have ... in delaying the vaccination schedules of the children resulting in ... ,According to the latest study, most of the ... years of age in children often gets delayed due to ...
... people it was found that men who drank six cups ... 12 to 18 years, while women who drank that amount ... their study revealed an unequivocal evidence for an inverse and ... other risk factors. However researchers say the reasons for ...
... paper presented at American College of Cardiology, laughter can ... presenter of the paper Michael Miller, MD, director of ... medicine at the University of Maryland in Baltimore, had ... healthy and 150 people suffering cardiac problems. ,The ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: